Related Experiment Videos

Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?

Robert C Hood¹

¹Endocrine Clinic of Southeast Texas , Beaumont, TX.

Diabetes Technology & Therapeutics

|April 19, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Trajectory of glycated haemoglobin over time, using real-world data, in type 2 diabetes patients with obesity on a U-100 basal-bolus insulin regimen.

Diabetes, obesity & metabolism·2023

Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2022

Treatment Patterns and Outcomes, Before and After Humulin R U-500 Initiation, Among High-Dose Type 2 Diabetes Mellitus Patients in the United States.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2021

The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2021

Concentrated insulins in current clinical practice.

Diabetes research and clinical practice·2018

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial.

Health and quality of life outcomes·2016

See all related articles